246 related articles for article (PubMed ID: 17054165)
1. Pharmacological management for agitation and aggression in people with acquired brain injury.
Fleminger S; Greenwood RJ; Oliver DL
Cochrane Database Syst Rev; 2006 Oct; (4):CD003299. PubMed ID: 17054165
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological management for agitation and aggression in people with acquired brain injury.
Fleminger S; Greenwood RJ; Oliver DL
Cochrane Database Syst Rev; 2003; (1):CD003299. PubMed ID: 12535468
[TBL] [Abstract][Full Text] [Related]
3. Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations.
Luauté J; Plantier D; Wiart L; Tell L;
Ann Phys Rehabil Med; 2016 Feb; 59(1):58-67. PubMed ID: 26700025
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews.
Rahmani E; Lemelle TM; Samarbafzadeh E; Kablinger AS
J Head Trauma Rehabil; 2021 Jul-Aug 01; 36(4):E262-E283. PubMed ID: 33656478
[TBL] [Abstract][Full Text] [Related]
5. A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.
Rahmani E; Lemelle T; Sharp H; Smarbafzadeh E; Kablinger A
J Clin Pharm Ther; 2022 Dec; 47(12):2083-2090. PubMed ID: 36543254
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Powney MJ; Adams CE; Jones H
Cochrane Database Syst Rev; 2012 Nov; 11():CD009377. PubMed ID: 23152276
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: A systematic review.
Mehta S; McIntyre A; Janzen S; Iruthayarajah J; Bateman A; Teasell R
Brain Inj; 2018; 32(3):287-296. PubMed ID: 29359952
[TBL] [Abstract][Full Text] [Related]
8. Valproate preparations for agitation in dementia.
Lonergan E; Luxenberg J
Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
[TBL] [Abstract][Full Text] [Related]
9. Treatment of agitation following traumatic brain injury: a review of the literature.
Levy M; Berson A; Cook T; Bollegala N; Seto E; Tursanski S; Kim J; Sockalingam S; Rajput A; Krishnadev N; Feng C; Bhalerao S
NeuroRehabilitation; 2005; 20(4):279-306. PubMed ID: 16403996
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
11. The treatment of agitation during initial hospitalization after traumatic brain injury.
Brooke MM; Patterson DR; Questad KA; Cardenas D; Farrel-Roberts L
Arch Phys Med Rehabil; 1992 Oct; 73(10):917-21. PubMed ID: 1417466
[TBL] [Abstract][Full Text] [Related]
12. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers and the treatment of aggression.
Haspel T
Harv Rev Psychiatry; 1995; 2(5):274-81. PubMed ID: 9384911
[TBL] [Abstract][Full Text] [Related]
14. [Agitation in head injury. II. Treatment with antidepressant, sympathomimetic, beta blocker , dopaminergic and other drugs].
Bascuñana H; Villarreal I; Alfonso S; Terré R; Bernabeu M
Rev Neurol; 2000 Jun 1-15; 30(11):1044-7. PubMed ID: 10904951
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol for agitation in dementia.
Lonergan E; Luxenberg J; Colford J
Cochrane Database Syst Rev; 2002; (2):CD002852. PubMed ID: 12076456
[TBL] [Abstract][Full Text] [Related]
16. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid for agitation in dementia.
Lonergan ET; Cameron M; Luxenberg J
Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
20. Management of faecal incontinence and constipation in adults with central neurological diseases.
Coggrave M; Norton C
Cochrane Database Syst Rev; 2013 Dec; (12):CD002115. PubMed ID: 24347087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
